An essential role of acetylcholine- glutamate synergy at habenular synapses in nicotine dependence

eLife

Volumn 4, Issue December2015, 2015, Pages

  Frahm, Silke ^a,c   Antolin Fontes, Beatriz ^a,b   Görlich, Andreas ^b   Zander, Johannes Friedrich ^c   Ahnert Hilger, Gudrun ^c   Ibañez Tallon, Ines ^a,b  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^b ROCKEFELLER UNIVERSITY   (United States)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; GLUTAMIC ACID;

ANIMAL; CHOLINERGIC NERVE CELL; CONDITIONED REFLEX; DRUG EFFECTS; HABENULA; METABOLISM; MOUSE; PHYSIOLOGY; SYNAPSE; TOBACCO DEPENDENCE;

ACETYLCHOLINE; ANIMALS; CHOLINERGIC NEURONS; CONDITIONING, CLASSICAL; GLUTAMIC ACID; HABENULA; MICE; SYNAPSES; TOBACCO USE DISORDER;

EID: 84955260168     PISSN: None     EISSN: 2050084X     Source Type: Journal    
DOI: 10.7554/eLife.11396     Document Type: Article

References (99)

1. Aizawa H, Kobayashi M, Tanaka S, Fukai T, Okamoto H. 2012. Molecular characterization of the subnuclei in rat habenula. The Journal of Comparative Neurology 520:4051-4066. doi: 10.1002/cne.23167
2. Allen TG, Abogadie FC, Brown DA. 2006. Simultaneous release of glutamate and acetylcholine from single magnocellular 'cholinergic' basal forebrain neurons. Journal of Neuroscience 26:1588-1595. doi: 10.1523/ JNEUROSCI.3979-05.2006
3. Antolin-Fontes B, Ables JL, Görlich A, Ibañez-Tallon I. 2015. The habenulo-interpeduncular pathway in nicotine aversion and withdrawal. Neuropharmacology 96 doi: 10.1016/j.neuropharm.2014.11.019
4. Bennett MR. 2000. The concept of transmitter receptors: 100 years on. Neuropharmacology 39:523-546. doi: 10.1016/S0028-3908(99)00137-9
5. Bergersen LH, Morland C, Ormel L, Rinholm JE, Larsson M, Wold JF, Røe AT, Stranna A, Santello M, Bouvier D, Ottersen OP, Volterra A, Gundersen V. 2012. Immunogold detection of l-glutamate and d-serine in small synaptic-like microvesicles in adult hippocampal astrocytes. Cerebral Cortex 22:1690-1697. doi: 10.1093/ cercor/bhr254
6. Bierut LJ, Madden PA, Breslau N, Johnson EO, Hatsukami D, Pomerleau OF, Swan GE, Rutter J, Bertelsen S, Fox L, Fugman D, Goate AM, Hinrichs AL, Konvicka K, Martin NG, Montgomery GW, Saccone NL, Saccone SF, Wang JC, Chase GA, Rice JP, Ballinger DG. 2007. Novel genes identified in a high-density genome wide association study for nicotine dependence. Human Molecular Genetics 16:24-35. doi: 10.1093/hmg/ddl441
7. Broms J, Antolin-Fontes B, Tingström A, Ibañez-Tallon I. 2015. Conserved expression of the GPR151 receptor in habenular axonal projections of vertebrates. The Journal of Comparative Neurology 523:359-380. doi: 10. 1002/cne.23664
8. Changeux JP. 2010. Nicotine addiction and nicotinic receptors: lessons from genetically modified mice. Nature Reviews. Neuroscience 11:389-401. doi: 10.1038/nrn2849
9. Clarke PB, Kumar R. 1983. The effects of nicotine on locomotor activity in non-tolerant and tolerant rats. British Journal of Pharmacology 78:329-337. doi: 10.1111/j.1476-5381.1983.tb09398.x
10. Contestabile A, Fonnum F. 1983. Cholinergic and GABAergic forebrain projections to the habenula and nucleus interpeduncularis: surgical and kainic acid lesions. Brain Research 275:287-297. doi: 10.1016/0006-8993(83) 90989-7
11. Costes SV, Daelemans D, Cho EH, Dobbin Z, Pavlakis G, Lockett S. 2004. Automatic and quantitative measurement of protein-protein colocalization in live cells. Biophysical Journal 86:3993-4003. doi: 10.1529/ biophysj.103.038422
12. Covernton PO, Lester RA. 2002. Prolonged stimulation of presynaptic nicotinic acetylcholine receptors in the rat interpeduncular nucleus has differential effects on transmitter release. International Journal of Developmental Neuroscience 20:247-258. doi: 10.1016/S0736-5748(02)00036-9
13. Damaj MI, Kao W, Martin BR. 2003. Characterization of spontaneous and precipitated nicotine withdrawal in the mouse. The Journal of Pharmacology and Experimental Therapeutics 307:526-534. doi: 10.1124/jpet.103. 054908
14. Dani JA, Bertrand D. 2007. Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system. Annual Review of Pharmacology and Toxicology 47:699-729. doi: 10.1146/annurev.pharmtox. 47.120505.105214
15. De Biasi M, Dani JA. 2011. Reward, addiction, withdrawal to nicotine. Annual Review of Neuroscience 34:105-130 doi: 10.1146/annurev-neuro-061010-113734
16. De-Miguel FF, Fuxe K. 2012. Extrasynaptic neurotransmission as a way of modulating neuronal functions. Frontiers in Physiology 3 doi: 10.3389/fphys.2012.00016
17. Descarries L, Gisiger V, Steriade M. 1997. Diffuse transmission by acetylcholine in the CNS. Progress in Neurobiology 53:603-625. doi: 10.1016/S0301-0082(97)00050-6
18. Descarries L, Mechawar N. 2000. Ultrastructural evidence for diffuse transmission by monoamine and acetylcholine neurons of the central nervous system. Progress in Brain Research 125:27-47. doi: 10.1016/ S0079-6123(00)25005-X
19. Dunn KW, Kamocka MM, McDonald JH. 2011. A practical guide to evaluating colocalization in biological microscopy. AJP: Cell Physiology 300:C723-C742. doi: 10.1152/ajpcell.00462.2010
20. El Mestikawy S, Wallén-Mackenzie A, Fortin GM, Descarries L, Trudeau LE. 2011. From glutamate co-release to vesicular synergy: vesicular glutamate transporters. Nature Reviews. Neuroscience 12:204-216. doi: 10.1038/ nrn2969
21. Everitt BJ, Robbins TW. 1997. Central cholinergic systems and cognition. Annual Review of Psychology 48:649-684. doi: 10.1146/annurev.psych.48.1.649
22. Flumerfelt BA, Contestabile A. 1982. Acetylcholinesterase histochemistry of the habenulo-interpeduncular pathway in the rat and the effects of electrolytic and kainic acid lesions. Anatomy and Embryology 163:435-446. doi: 10.1007/BF00305557
23. Fowler CD, Lu Q, Johnson PM, Marks MJ, Kenny PJ. 2011. Habenular a5 nicotinic receptor subunit signalling controls nicotine intake. Nature 471:597-601. doi: 10.1038/nature09797
24. Fowler CD, Tuesta L, Kenny PJ. 2013. Role of a5* nicotinic acetylcholine receptors in the effects of acute and chronic nicotine treatment on brain reward function in mice. Psychopharmacology doi: 10.1007/s00213-013- 3235-1
25. Frahm S, Slimak MA, Ferrarese L, Santos-Torres J, Antolin-Fontes B, Auer S, Filkin S, Pons S, Fontaine JF, Tsetlin V, Maskos U, Ibañez-Tallon I. 2011. Aversion to nicotine is regulated by the balanced activity of b4 and a5 nicotinic receptor subunits in the medial habenula. Neuron 70:522-535. doi: 10.1016/j.neuron.2011.04.013
26. Franklin K, Paxinos G. 2008. The mouse brain in stereotaxic coordinates. (3rd Ed) San Diego, California: Academic press.
27. Geisler S, Wise RA. 2008. Functional implications of glutamatergic projections to the ventral tegmental area. Reviews in the Neurosciences 19:227-244. doi: 10.1515/REVNEURO.2008.19.4-5.227
28. Gilmor ML, Nash NR, Roghani A, Edwards RH, Yi H, Hersch SM, Levey AI. 1996. Expression of the putative vesicular acetylcholine transporter in rat brain and localization in cholinergic synaptic vesicles. Journal of Neuroscience 16:2179-2190.
29. Giniatullin R, Nistri A, Yakel JL. 2005. Desensitization of nicotinic ACh receptors: shaping cholinergic signaling. Trends in Neurosciences 28:371-378. doi: 10.1016/j.tins.2005.04.009
30. Girod R, Barazangi N, McGehee D, Role LW. 2000. Facilitation of glutamatergic neurotransmission by presynaptic nicotinic acetylcholine receptors. Neuropharmacology 39:2715-2725. doi: 10.1016/S0028-3908(00) 00145-3
31. Girod R, Role LW. 2001. Long-lasting enhancement of glutamatergic synaptic transmission by acetylcholine contrasts with response adaptation after exposure to low-level nicotine. Journal of Neuroscience 21:5182- 5190.
32. Gong S, Zheng C, Doughty ML, Losos K, Didkovsky N, Schambra UB, Nowak NJ, Joyner A, Leblanc G, Hatten ME, Heintz N. 2003. A gene expression atlas of the central nervous system based on bacterial artificial chromosomes. Nature 425:917-925. doi: 10.1038/nature02033
33. Gorlich A, Antolin-Fontes B, Ables JL, Frahm S, Slimak MA, Dougherty JD, Ibanez-Tallon I. 2013. Reexposure to nicotine during withdrawal increases the pacemaking activity of cholinergic habenular neurons. Proceedings of the National Academy of Sciences 110:17077-17082. doi: 10.1073/pnas.1313103110
34. Gottesfeld Z, Jacobowitz DM. 1979. Cholinergic projections from the septal-diagonal band area to the habenular nuclei. Brain Research 176:391-394.
35. Grabus SD, Martin BR, Batman AM, Tyndale RF, Sellers E, Damaj MI. 2005. Nicotine physical dependence and tolerance in the mouse following chronic oral administration. Psychopharmacology 178:183-192. doi: 10.1007/ s00213-004-2007-3
36. Grady SR, Moretti M, Zoli M, Marks MJ, Zanardi A, Pucci L, Clementi F, Gotti C. 2009. Rodent habenulo- interpeduncular pathway expresses a large variety of uncommon nAChR subtypes, but only the alpha3beta4* and alpha3beta3beta4* subtypes mediate acetylcholine release. Journal of Neuroscience 29:2272-2282. doi: 10.1523/JNEUROSCI.5121-08.2009
37. Gras C, Amilhon B, Lepicard EM, Poirel O, Vinatier J, Herbin M, Dumas S, Tzavara ET, Wade MR, Nomikos GG, Hanoun N, Saurini F, Kemel ML, Gasnier B, Giros B, El Mestikawy S. 2008. The vesicular glutamate transporter VGLUT3 synergizes striatal acetylcholine tone. Nature Neuroscience 11:292-300. doi: 10.1038/nn2052
38. Gritti I, Henny P, Galloni F, Mainville L, Mariotti M, Jones BE. 2006. Stereological estimates of the basal forebrain cell population in the rat, including neurons containing choline acetyltransferase, glutamic acid decarboxylase or phosphate-activated glutaminase and colocalizing vesicular glutamate transporters. Neuroscience 143:1051-1064. doi: 10.1016/j.neuroscience.2006.09.024
39. Gundersen V, Chaudhry FA, Bjaalie JG, Fonnum F, Ottersen OP, Storm-Mathisen J. 1998. Synaptic vesicular localization and exocytosis of l-aspartate in excitatory nerve terminals: a quantitative immunogold analysis in rat hippocampus. Journal of Neuroscience 18:6059-6070.
40. Guzman MS, De Jaeger X, Raulic S, Souza IA, Li AX, Schmid S, Menon RS, Gainetdinov RR, Caron MG, Bartha R, Prado VF, Prado MA. 2011. Elimination of the vesicular acetylcholine transporter in the striatum reveals regulation of behaviour by cholinergic-glutamatergic co-transmission. PLoS Biology 9:e1001194 doi: 10.1371/ journal.pbio.1001194
41. Heitjan DF, Guo M, Ray R, Wileyto EP, Epstein LH, Lerman C. 2008. Identification of pharmacogenetic markers in smoking cessation therapy. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics 147B: 712-719. doi: 10.1002/ajmg.b.30669
42. Henderson Z, Lu CB, JanzsóG, Matto N, McKinley CE, Yanagawa Y, Halasy K. 2010. Distribution and role of Kv3. 1b in neurons in the medial septum diagonal band complex. Neuroscience 166:952-969. doi: 10.1016/j. neuroscience.2010.01.020
43. Henny P, Jones BE. 2008. Projections from basal forebrain to prefrontal cortex comprise cholinergic, GABAergic and glutamatergic inputs to pyramidal cells or interneurons. The European Journal of Neuroscience 27:654-670. doi: 10.1111/j.1460-9568.2008.06029.x
44. Hnasko TS, Chuhma N, Zhang H, Goh GY, Sulzer D, Palmiter RD, Rayport S, Edwards RH. 2010. Vesicular glutamate transport promotes dopamine storage and glutamate corelease in vivo. Neuron 65:643-656. doi: 10. 1016/j.neuron.2010.02.012
45. Hnasko TS, Edwards RH. 2012. Neurotransmitter corelease: mechanism and physiological role. Annual Review of Physiology 74:225-243. doi: 10.1146/annurev-physiol-020911-153315
46. Jackson KJ, Marks MJ, Vann RE, Chen X, Gamage TF, Warner JA, Damaj MI. 2010. Role of alpha5 nicotinic acetylcholine receptors in pharmacological and behavioral effects of nicotine in mice. The Journal of Pharmacology and Experimental Therapeutics 334:137-146. doi: 10.1124/jpet.110.165738
47. Jackson KJ, Sanjakdar SS, Muldoon PP, McIntosh JM, Damaj MI. 2013. The a3b4* nicotinic acetylcholine receptor subtype mediates nicotine reward and physical nicotine withdrawal signs independently of the a5 subunit in the mouse. Neuropharmacology 70:228-235. doi: 10.1016/j.neuropharm.2013.01.017
48. Kalivas PW. 2009. The glutamate homeostasis hypothesis of addiction. Nature Reviews. Neuroscience 10:561-572. doi: 10.1038/nrn2515
49. Kawaja MD, Flumerfelt BA, Hrycyshyn AW. 1989. Glutamate decarboxylase immunoreactivity in the rat interpeduncular nucleus: a light and electron microscope investigation. Neuroscience 30:741-753. doi: 10. 1016/0306-4522(89)90166-8
50. Kenny PJ, Markou A. 2001. Neurobiology of the nicotine withdrawal syndrome. Pharmacology Biochemistry and Behavior 70:531-549. doi: 10.1016/S0091-3057(01)00651-7
51. Kuffler SW, Yoshikami D. 1975. The number of transmitter molecules in a quantum: an estimate from iontophoretic application of acetylcholine at the neuromuscular synapse. The Journal of Physiology 251:465-482. doi: 10.1113/jphysiol.1975.sp011103
52. Kumasaka N, Aoki M, Okada Y, Takahashi A, Ozaki K, Mushiroda T, Hirota T, Tamari M, Tanaka T, Nakamura Y, Kamatani N, Kubo M. 2012. Haplotypes with copy number and single nucleotide polymorphisms in CYP2A6 locus are associated with smoking quantity in a japanese population. PloS One 7:e44507 doi: 10.1371/journal. pone.0044507
53. Léna C, Changeux JP, Mulle C. 1993. Evidence for "preterminal" nicotinic receptors on GABAergic axons in the rat interpeduncular nucleus. Journal of Neuroscience 13:2680-2688.
54. Lenn NJ, Leranth C, Zaborszky L. 1985. Choline acetyltransferase immunoreactivity is localized to four types of synapses in the rat interpeduncular nucleus. Journal of Neurocytology 14:909-919. doi: 10.1007/BF01224804
55. Li H, Harlow ML. 2014. Individual synaptic vesicles from the electroplaque of torpedo californica, a classic cholinergic synapse, also contain transporters for glutamate and ATP. Physiological Reports 2:e00206 doi: 10. 1002/phy2.206
56. Liu G, Choi S, Tsien RW. 1999. Variability of neurotransmitter concentration and nonsaturation of postsynaptic AMPA receptors at synapses in hippocampal cultures and slices. Neuron 22:395-409. doi: 10.1016/S0896-6273 (00)81099-5
57. Loewi O. 1921. Über humorale übertragbarkeit der herznervenwirkung. Pflügers Archiv Für Die Gesamte Physiologie Des Menschen Und Der Tiere 189:239-242. doi: 10.1007/BF01738910
58. Manders EMM, Verbeek FJ, Aten JA. 1993. Measurement of co-localization of objects in dual-colour confocal images. Journal of Microscopy 169:375-382. doi: 10.1111/j.1365-2818.1993.tb03313.x
59. Mansvelder HD, Keath JR, McGehee DS. 2002. Synaptic mechanisms underlie nicotine-induced excitability of brain reward areas. Neuron 33:905-919. doi: 10.1016/S0896-6273(02)00625-6
60. Mansvelder HD, Mertz M, Role LW. 2009. Nicotinic modulation of synaptic transmission and plasticity in cortico- limbic circuits. Seminars in Cell & Developmental Biology 20:432-440. doi: 10.1016/j.semcdb.2009.01.007
61. Marra V, Burden JJ, Thorpe JR, Smith IT, Smith SL, Häusser M, Branco T, Staras K. 2012. A preferentially segregated recycling vesicle pool of limited size supports neurotransmission in native central synapses. Neuron 76:579-589. doi: 10.1016/j.neuron.2012.08.042
62. Maskos U, Molles BE, Pons S, Besson M, Guiard BP, Guilloux JP, Evrard A, Cazala P, Cormier A, Mameli-Engvall M, Dufour N, Cloëz-Tayarani I, Bemelmans AP, Mallet J, Gardier AM, David V, Faure P, Granon S, Changeux JP. 2005. Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors. Nature 436:103-107. doi: 10.1038/nature03694
63. McGehee D, Heath M, Gelber S, Devay P, Role L. 1995. Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors. Science 269:1692-1696. doi: 10.1126/science.7569895
64. Mesulam MM, Mufson EJ, Levey AI, Wainer BH. 1983. Cholinergic innervation of cortex by the basal forebrain: cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (substantia innominata), and hypothalamus in the rhesus monkey. The Journal of Comparative Neurology 214:170-197. doi: 10.1002/cne.902140206
65. Misgeld T, Burgess RW, Lewis RM, Cunningham JM, Lichtman JW, Sanes JR. 2002. Roles of neurotransmitter in synapse formation. Neuron 36:635-648. doi: 10.1016/S0896-6273(02)01020-6
66. Nishimaru H, Restrepo CE, Ryge J, Yanagawa Y, Kiehn O. 2005. Mammalian motor neurons corelease glutamate and acetylcholine at central synapses. Proceedings of the National Academy of Sciences 102:5245-5249. doi: 10.1073/pnas.0501331102
67. Parajuli LK, Nakajima C, Kulik A, Matsui K, Schneider T, Shigemoto R, Fukazawa Y. 2012. Quantitative regional and ultrastructural localization of the ca(v)2.3 subunit of r-type calcium channel in mouse brain. Journal of Neuroscience 32:13555-13567. doi: 10.1523/JNEUROSCI.1142-12.2012
68. Perry DC, Xiao Y, Nguyen HN, Musachio JL, Dávila-García MI, Kellar KJ. 2002. Measuring nicotinic receptors with characteristics of a4b2, a3b2 and a3b4 subtypes in rat tissues by autoradiography. Journal of Neurochemistry 82:468-481. doi: 10.1046/j.1471-4159.2002.00951.x
69. Picciotto MR, Higley MJ, Mineur YS. 2012. Acetylcholine as a neuromodulator: cholinergic signaling shapes nervous system function and behavior. Neuron 76:116-129. doi: 10.1016/j.neuron.2012.08.036
70. Pinheiro PS, Mulle C. 2008. Presynaptic glutamate receptors: physiological functions and mechanisms of action. Nature Reviews. Neuroscience 9:423-436. doi: 10.1038/nrn2379
71. Preobraschenski J, Zander JF, Suzuki T, Ahnert-Hilger G, Jahn R. 2014. Vesicular glutamate transporters use flexible anion and cation binding sites for efficient accumulation of neurotransmitter. Neuron 84:1287-1301. doi: 10.1016/j.neuron.2014.11.008
72. Quina LA, Wang S, Ng L, Turner EE. 2009. Brn3a and Nurr1 mediate a gene regulatory pathway for habenula development. Journal of Neuroscience 29:14309-14322. doi: 10.1523/JNEUROSCI.2430-09.2009
73. Quinn DM. 1987. Acetylcholinesterase: enzyme structure, reaction dynamics, and virtual transition states. Chemical Reviews 87:955-979. doi: 10.1021/cr00081a005
74. Ray R, Mitra N, Baldwin D, Guo M, Patterson F, Heitjan DF, Jepson C, Wileyto EP, Wei J, Payne T, Ma JZ, Li MD, Lerman C. 2010. Convergent evidence that choline acetyltransferase gene variation is associated with prospective smoking cessation and nicotine dependence. Neuropsychopharmacology 35:1374-1382. doi: 10. 1038/npp.2010.7
75. Ren J, Qin C, Hu F, Tan J, Qiu L, Zhao S, Feng G, Luo M. 2011. Habenula "cholinergic" neurons co-release glutamate and acetylcholine and activate postsynaptic neurons via distinct transmission modes. Neuron 69: 445-452. doi: 10.1016/j.neuron.2010.12.038
76. Rizzoli SO, Betz WJ. 2005. Synaptic vesicle pools. Nature Reviews. Neuroscience 6:57-69. doi: 10.1038/nrn1583
77. Rizzoli SO. 2014. Synaptic vesicle recycling: steps and principles. The EMBO Journal 33:788-822. doi: 10.1002/ embj.201386357
78. Role LW, Berg DK. 1996. Nicotinic receptors in the development and modulation of CNS synapses. Neuron 16: 1077-1085.
79. Rosenberry TL. 1975. Acetylcholinesterase. Advances in Enzymology and Related Areas of Molecular Biology 43: 103-218.
80. Saccone NL, Wang JC, Breslau N, Johnson EO, Hatsukami D, Saccone SF, Grucza RA, Sun L, Duan W, Budde J, Culverhouse RC, Fox L, Hinrichs AL, Steinbach JH, Wu M, Rice JP, Goate AM, Bierut LJ. 2009. The CHRNA5- CHRNA3-CHRNB4 nicotinic receptor subunit gene cluster affects risk for nicotine dependence in african- americans and in european-americans. Cancer Research 69:6848-6856. doi: 10.1158/0008-5472.CAN-09-0786
81. Salas R, Pieri F, De Biasi M. 2004. Decreased signs of nicotine withdrawal in mice null for the beta4 nicotinic acetylcholine receptor subunit. Journal of Neuroscience 24:10035-10039. doi: 10.1523/JNEUROSCI.1939-04. 2004
82. Salas R, Sturm R, Boulter J, De Biasi M. 2009. Nicotinic receptors in the habenulo-interpeduncular system are necessary for nicotine withdrawal in mice. Journal of Neuroscience 29:3014-3018. doi: 10.1523/JNEUROSCI. 4934-08.2009
83. Sarter M, Parikh V, Howe WM. 2009. Phasic acetylcholine release and the volume transmission hypothesis: time to move on. Nature Reviews. Neuroscience 10:383-390. doi: 10.1038/nrn2635
84. Shabel SJ, Proulx CD, Piriz J, Malinow R. 2014. Mood regulation. GABA/glutamate co-release controls habenula output and is modified by antidepressant treatment. Science 345:1494-1498. doi: 10.1126/science.1250469
85. Stensrud MJ, Chaudhry FA, Leergaard TB, Bjaalie JG, Gundersen V. 2013. Vesicular glutamate transporter-3 in the rodent brain: vesicular colocalization with vesicular g-aminobutyric acid transporter. The Journal of Comparative Neurology 521:3042-3056. doi: 10.1002/cne.23331
86. Takamori S, Riedel D, Jahn R. 2000. Immunoisolation of GABA-specific synaptic vesicles defines a functionally distinct subset of synaptic vesicles. Journal of Neuroscience 20:4904-4911.
87. Tapper AR, McKinney SL, Nashmi R, Schwarz J, Deshpande P, Labarca C, Whiteaker P, Marks MJ, Collins AC, Lester HA. 2004. Nicotine activation of alpha4* receptors: sufficient for reward, tolerance, and sensitization. Science 306:1029-1032. doi: 10.1126/science.1099420
88. Tapper AR, McKinney SL, Marks MJ, Lester HA. 2007. Nicotine responses in hypersensitive and knockout alpha 4 mice account for tolerance to both hypothermia and locomotor suppression in wild-type mice. Physiological Genomics 31:422-428. doi: 10.1152/physiolgenomics.00063.2007
89. Thorgeirsson TE, Gudbjartsson DF, Surakka I, Vink JM, Amin N, Geller F, Sulem P, Rafnar T, Esko T, Walter S, Gieger C, Rawal R, Mangino M, Prokopenko I, Mägi R, Keskitalo K, Gudjonsdottir IH, Gretarsdottir S, Stefansson H, Thompson JR, Aulchenko YS, Nelis M, Aben KK, den Heijer M, Dirksen A, Ashraf H, Soranzo N, Valdes AM, Steves C, Uitterlinden AG, Hofman A, Tönjes A, Kovacs P, Hottenga JJ, Willemsen G, Vogelzangs N, Döring A, Dahmen N, Nitz B, Pergadia ML, Saez B, De Diego V, Lezcano V, Garcia-Prats MD, Ripatti S, Perola M, Kettunen J, Hartikainen AL, Pouta A, Laitinen J, Isohanni M, Huei-Yi S, Allen M, Krestyaninova M, Hall AS, Jones GT, van Rij AM, Mueller T, Dieplinger B, Haltmayer M, Jonsson S, Matthiasson SE, Oskarsson H, Tyrfingsson T, Kiemeney LA, Mayordomo JI, Lindholt JS, Pedersen JH, Franklin WA, Wolf H, Montgomery GW, Heath AC, Martin NG, Madden PA, Giegling I, Rujescu D, Järvelin MR, Salomaa V, Stumvoll M, Spector TD, Wichmann HE, Metspalu A, Samani NJ, Penninx BW, Oostra BA, Boomsma DI, Tiemeier H, van Duijn CM, Kaprio J, Gulcher JR, McCarthy MI, Peltonen L, Thorsteinsdottir U, Stefansson K.ENGAGE ConsortiumENGAGE Consortium. 2010. Sequence variants at CHRNB3-CHRNA6 and CYP2A6 affect smoking behavior. Nature Genetics 42:448-453. doi: 10.1038/ng.573
90. Tritsch NX, Oh W-J, Gu C, Sabatini BL. 2014. Midbrain dopamine neurons sustain inhibitory transmission using plasma membrane uptake of GABA, not synthesis. eLife 3:e01936 doi: 10.7554/eLife.01936
91. Turner JR, Gold A, Schnoll R, Blendy JA. 2013. Translational research in nicotine dependence. Cold Spring Harbor Perspectives in Medicine 3:a012153 doi: 10.1101/cshperspect.a012153
92. Wang HL, Morales M. 2009. Pedunculopontine and laterodorsal tegmental nuclei contain distinct populations of cholinergic, glutamatergic and GABAergic neurons in the rat. The European Journal of Neuroscience 29:340-358. doi: 10.1111/j.1460-9568.2008.06576.x
93. Watt AJ, van Rossum MCW, MacLeod KM, Nelson SB, Turrigiano GG. 2000. Activity coregulates quantal AMPA and NMDA currents at neocortical synapses. Neuron 26:659-670. doi: 10.1016/S0896-6273(00)81202-7
94. Wei J, Ma JZ, Payne TJ, Cui W, Ray R, Mitra N, Lerman C, Li MD. 2010. Replication and extension of association of choline acetyltransferase with nicotine dependence in european and african american smokers. Human Genetics 127:691-698. doi: 10.1007/s00439-010-0818-3
95. West RJ, Hajek P, Belcher M. 1989. Severity of withdrawal symptoms as a predictor of outcome of an attempt to quit smoking. Psychological Medicine 19:981-985. doi: 10.1017/S0033291700005705
96. Zander JF, Münster-Wandowski A, Brunk I, Pahner I, Gómez-Lira G, Heinemann U, Gutiérrez R, Laube G, Ahnert- Hilger G. 2010. Synaptic and vesicular coexistence of VGLUT and VGAT in selected excitatory and inhibitory synapses. Journal of Neuroscience 30:7634-7645. doi: 10.1523/JNEUROSCI.0141-10.2010
97. Zhao-Shea R, Liu L, Pang X, Gardner PD, Tapper AR. 2013. Activation of GABAergic neurons in the interpeduncular nucleus triggers physical nicotine withdrawal symptoms. Current Biology 23:2327-2335. doi: 10.1016/j.cub.2013.09.041
98. Zinchuk V, Zinchuk O. 2008. Quantitative colocalization analysis of confocal fluorescence microscopy images. Current Protocols in Cell Biology 4.19 doi: 10.1002/0471143030.cb0419s39
99. Zoli M, Le Novère N, Hill JA, Changeux JP. 1995. Developmental regulation of nicotinic ACh receptor subunit mRNAs in the rat central and peripheral nervous systems. Journal of Neuroscience 15:1912-1939.